ObesiD is an Australian-first clinical resource for dosing in patients with obesity. It offer concise guidance on the principles of dosing in obesity,
evidence-based advice for more than 70 medicines and body weight calculators in a modern digital app experience.
In 2022, approximately 32% of Australian adults were living with obesity and a further 34% were overweight. In the last decade, the proportion of adults with obesity has increased.
What's in your ObesiD subscription?
Concise guidance on dosing principles for patients with obesity
Evidence-based advice for 70+ medicines
Offline mode for access anytime, anywhere
Modern dedicated mobile apps for iOS and Android
A body weight calculator
Regular updates
Integrated access for Therapeutic Guidelines and ObesiD web apps*
Subscriptions for single and institutional users are now available.
*Quickly access Therapeutic Guidelines and ObesiD web apps with one subscription (feature available for
single user accounts). Users must subscribe as a single user with the same email addresses to ensure integrated access
between the two web apps.
